Merck KGaA (FRA:MRK) received a €112.00 ($125.84) price target from investment analysts at equinet AG in a research note issued to investors on Monday. The firm presently has a “neutral” rating on the healthcare company’s stock.

A number of other equities research analysts have also weighed in on MRK. JPMorgan Chase & Co. restated a “neutral” rating on shares of Merck KGaA in a research note on Monday, February 27th. BNP Paribas set a €114.00 ($128.09) price target on Merck KGaA and gave the stock a “buy” rating in a research note on Tuesday, February 28th. Citigroup Inc. set a €116.00 ($130.34) price target on Merck KGaA and gave the stock a “buy” rating in a research note on Wednesday, March 1st. Warburg Research set a €110.00 ($123.60) price target on Merck KGaA and gave the stock a “buy” rating in a research note on Thursday, March 9th. Finally, Commerzbank Ag set a €109.00 ($122.47) price target on Merck KGaA and gave the stock a “neutral” rating in a research note on Thursday, March 9th. One research analyst has rated the stock with a sell rating, fifteen have given a hold rating and seven have assigned a buy rating to the stock. The stock has an average rating of “Hold” and a consensus target price of €111.09 ($124.82).

Merck KGaA (FRA:MRK) traded up 0.179% during trading on Monday, reaching €111.114. 332 shares of the company’s stock traded hands. The firm has a market cap of €48.24 billion and a price-to-earnings ratio of 30.977. Merck KGaA has a one year low of €80.99 and a one year high of €115.00. The company has a 50 day moving average of €108.18 and a 200 day moving average of €103.68.

ILLEGAL ACTIVITY NOTICE: This piece was originally reported by American Banking News and is owned by of American Banking News. If you are viewing this piece on another website, it was illegally stolen and republished in violation of United States and international copyright and trademark law. The legal version of this piece can be accessed at https://www.americanbankingnews.com/2017/06/26/merck-kgaa-mrk-given-a-112-00-price-target-at-equinet-ag.html.

About Merck KGaA

.

Analyst Recommendations for Merck KGaA (FRA:MRK)

Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.